Quick Answer
NEUROCRINE BIOSCIENCES INC reported Common Stock Shares Outstanding of 100.10 million shares for the year ending 2025.
- NEUROCRINE BIOSCIENCES INC showed an increase of +0.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from NEUROCRINE BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: 55.24 million shares | Q3 2011: 55.25 million shares | Q1 2012: 66.31 million shares | Q2 2012: 66.32 million shares | Q3 2012: 66.38 million shares | Q1 2013: 66.71 million shares | Q2 2013: 67.00 million shares | Q3 2013: 67.34 million shares | Q1 2014: 75.86 million shares | Q2 2014: 75.92 million shares | Q3 2014: 76.00 million shares | Q1 2015: 85.37 million shares | Q2 2015: 85.75 million shares | Q3 2015: 85.88 million shares | Q1 2016: 86.57 million shares | Q2 2016: 86.75 million shares | Q3 2016: 86.87 million shares | Q1 2017: 87.52 million shares | Q2 2017: 88.22 million shares | Q3 2017: 88.46 million shares | Q1 2018: 89.88 million shares | Q2 2018: 90.40 million shares | Q3 2018: 90.67 million shares | Q1 2019: 91.28 million shares | Q2 2019: 91.54 million shares | Q3 2019: 92.08 million shares | Q1 2020: 92.80 million shares | Q2 2020: 93.20 million shares | Q3 2020: 93.40 million shares | Q1 2021: 94.50 million shares | Q2 2021: 94.60 million shares | Q3 2021: 94.80 million shares | Q1 2022: 95.50 million shares | Q2 2022: 95.60 million shares | Q3 2022: 96.10 million shares | Q1 2023: 97.50 million shares | Q2 2023: 97.60 million shares | Q3 2023: 98.20 million shares | Q1 2024: 100.60 million shares | Q2 2024: 100.90 million shares | Q3 2024: 101.20 million shares | Q1 2025: 99.00 million shares | Q2 2025: 99.00 million shares | Q3 2025: 99.70 million shares.
- Over the full 16 years of available data (2010 to 2025), NEUROCRINE BIOSCIENCES INC's Common Stock Shares Outstanding has grown by 82.4%.
- Historical annual values: Fiscal year 2025: 100.10 million shares | Fiscal year 2024: 99.40 million shares | Fiscal year 2023: 98.70 million shares | Fiscal year 2022: 96.50 million shares | Fiscal year 2021: 94.90 million shares | Fiscal year 2020: 93.50 million shares | Fiscal year 2019: 92.30 million shares | Fiscal year 2018: 90.80 million shares | Fiscal year 2017: 88.79 million shares | Fiscal year 2016: 86.88 million shares | Fiscal year 2015: 86.26 million shares | Fiscal year 2014: 76.47 million shares | Fiscal year 2013: 67.35 million shares | Fiscal year 2012: 66.45 million shares | Fiscal year 2011: 55.26 million shares | Fiscal year 2010: 54.88 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: